Current nanotechnological strategies for an effective delivery of drugs in treatment of periodontal disease

Critical Reviews in Therapeutic Drug Carrier Systems

Volumn 31, Issue 2, 2014, Pages 89-119

  Goyal, Gagan ^a   Garg, Tarun ^a   Rath, Goutam ^a   Goyal, Amit K ^a  

^a ISF COLLEGE OF PHARMACY   (India)

Author keywords

Fibers; Films; Gingivitis; Implants; Periodontitis; Strips

Indexed keywords

ALENDRONIC ACID; ALGINIC ACID; ANTIBIOTIC AGENT; CEFALEXIN; CHITOSAN; CHLORHEXIDINE; COLLAGEN; DICLOFENAC; DOXYCYCLINE; EFENAMIC ACID; ETHYL CELLULOSE; HYDROXYPROPYLCELLULOSE; INDOMETACIN; IPRIFLAVONE; KETOPROFEN; LIPOSOME; MACROGOL; MAGNESIUM HYDROXIDE; MATRIX METALLOPROTEINASE; METRONIDAZOLE; MICROSPHERE; MINOCYCLINE; NANOPARTICLE; NIRIDAZOLE; POLYACRYLIC ACID; POLYMER; TETRACYCLINE; TINIDAZOLE; TRICLOSAN; UNINDEXED DRUG;

ARTICLE; DRUG DELIVERY SYSTEM; GINGIVITIS; HUMAN; HYDROGEL; INFLAMMATION; NANOTECHNOLOGY; PERIODONTAL DISEASE; PERIODONTAL POCKET; PERIODONTITIS; PREVALENCE; RISK FACTOR; SMOKING; STREPTOCOCCUS SANGUINIS; T LYMPHOCYTE ACTIVATION; TOOTH IMPLANT; TOOTH PLAQUE; DRUG ADMINISTRATION ROUTE; PATHOPHYSIOLOGY; PERIODONTAL DISEASES;

DRUG ADMINISTRATION ROUTES; HUMANS; NANOTECHNOLOGY; PERIODONTAL DISEASES;

EID: 84896470946     PISSN: 07434863     EISSN: 2162660X     Source Type: Journal    
DOI: 10.1615/CritRevTherDrugCarrierSyst.2014008117     Document Type: Article

References (144)

1. Hung SL, Lee NG, Chang LY, Chen YT, Lai YL. Stimulatory effects of glucose and lipopolysaccharide of porphyromonas gingivalis on the secretion of inflammatory mediators from human macrophages. J Periodontol. 2014;85(1):140-9
2. Garala K, Joshi P, Shah M, Ramkishan A, Patel J. Formulation and evaluation of periodontal in situ gel. Int J Pharm Invest. 2013;3(1):29-41.
3. Bermejo-Fenoll A, Sanchez-Perez A. Necrotising periodontal diseases. Med Oral Pat Oral Cir Bucal. 2004;9:108-14.
4. Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet. 2005;366(9499):1809-20.
5. Ahghari H. Healthy mouth equals healthy body. Acta Endocrinol (Copenh). 1975;78(2):239-50.
6. Jacob S. Global prevalence of periodontitis: a literarure review. Int Arab J Dent. 2012;3(1):26-30.
7. Nishimura F, Iwashita M, Yamashita A. [Periodontal disease]. Nihon Rinsho. 2012;5:499-502.
8. Bullon P, Cordero MD, Quiles JL, Ramirez-Tortosa Mdel C, Gonzalez-Alonso A, Alfonsi S. Autophagy in periodontitis patients and gingival fibroblasts: unraveling the link between chronic diseases and inflammation. BMC Med. 2012;10(122):1741-61.
9. Monini Ada C, Guimaraes Mde S, Gandini Junior LG, Santos-Pinto L, Hebling J. Tooth separation: a risk-free procedure? Am J Orthod Dentofacial Orthop. 2012;142(3):402-5.
10. Güncü G, Tözüm T, Caglayan F. Effects of endogenous sex hormones on the periodontium-review of literature. Austral Dent J. 2005;50(3):138-45.
11. Mealey BL. Periodontal disease and diabetes: a two-way street. J Am Dent Assoc. 2006;137(suppl 2):26S-31S.
12. Lemos SS, Oliveira FA, Vencio EF. Periodontal disease and oral hygiene benefits in HIV seropositive and AIDS patients. Med Oral Patol Oral Cir Bucal. 2010;15(2):e417-21.
13. Meyer MS, Joshipura K, Giovannucci E, Michaud DS. A review of the relationship between tooth loss, periodontal disease, and cancer. Cancer Causes Control. 2008;19(9):895-907.
14. Suzuki AM, Yoshimura A, Ozaki Y, Kaneko T, Hara Y. Cyclosporin A and phenytoin modulate inflammatory responses. J Dent Res. 2009;88(12):1131-6.
15. Pizzo G, Lo Re D, Piscopo MR, Pizzo I, Giuliana G. Genetic disorders and periodontal health: a literature review. Med Sci Monit. 2009;15(8):RA167-78.
16. Bernimoulin JP. Recent concepts in plaque formation. J Clin Periodontol. 2003;5:7-9.
17. Seminario A, Broukal Z, Ivancakova R. Mutans streptococci and the development of dental plaque. Prague Med Rep. 2005;106(4):349-58.
18. Anderson MR. Oral hygiene powder composition and method. J Clin Periodontol. 1979;6(2):115-30.
19. Monteiro AM, Jardini MA, Giampaoli V, Alves S, Figueiredo Neto AM, Gidlund M. Measurement of the nonlinear optical response of low-density lipoprotein solutions from patients with periodontitis before and after periodontal treatment: evaluation of cardiovascular risk markers. J Biomed Opt. 2012;17(11):115004.
20. Ji QX, Zhao QS, Deng J, Lu R. A novel injectable chlorhexidine thermosensitive hydrogel for periodontal application: preparation, antibacterial activity and toxicity evaluation. J Mater Sci Mater Med. 2010;21(8):2435-42.
21. Ozmeric N, Ozcan G, Haytac CM, Alaaddinoglu EE, Sargon MF, Senel S. Chitosan film enriched with an antioxidant agent, taurine, in fenestration defects. J Biomed Mater Res. 2000;51(3):500-3.
22. Akncbay H, Senel S, Ay ZY. Application of chitosan gel in the treatment of chronic periodontitis. J Biomed Mater Res Part B. 2007;80(2):290-6.
23. Rao CB, Mohammed SA, Alokbe TO, Awen BZ, Katakam P. Design and in-vitro evaluation of controlled release cephalexin subgingival films using natural biodegradable polymer. Recent Res Sci Technol. 2010;2(4),6-11.
24. Aronna G, De Rosa A, Rosso F, Margarucci S, Caruso F. [A biocompatibility study and the effects of slow-release antibiotic materials in the treatment of periodontal disease. II. the biocompatibility and behavior of polyhydroxyethyl methacrylate (pHEMA) as a slow-release material for tetracycline of metronidazole. a study of 2 cases]. Minerva Stomatol. 1998;47(10):559-64.
25. Cetin EO, Buduneli N, Atlihan E, Kirilmaz L. In vitro studies on controlled-release cellulose acetate films for local delivery of chlorhexidine, indomethacin, and meloxicam. J Clin Periodontol. 2004;31(12):1117-21.
26. Somayaji BV, Jariwala U, Jayachandran P, Vidyalakshmi K, Dudhani RV. Evaluation of antimicrobial efficacy and release pattern of tetracycline and metronidazole using a local delivery system. J Periodontol. 1998;69(4):409-13.
27. Barat R, Srinatha A, Pandit JK, Mittal N, Anupurba S. Ethylcellulose inserts of an orphan drug for periodontitis: preparation, in vitro, and clinical studies. Drug Deliv. 2007;14(8):531-8.
28. Verma A, Sanghi S, Grover D, Aggarwal S, Gupta R, Pandit N. Effect of insertion of xanthan-based chlorhexidine gel in the maintenance phase following the treatment of chronic periodontitis. J Indian Soc Periodontol. 2012;16(3):381-5.
29. Shweta B, Anoop B, Dakshina B, Sadaf N. Evaluation of efficacy of tetracycline fibers in conjunction with scaling and root planing in patients with chronic periodontitis. J Indian Soc Periodontol. 2012;1:392-7.
30. Gamal AY, Kumper RM. A novel approach to the use of doxycycline-loaded biodegradable membrane and EDTA root surface etching in chronic periodontitis: a randomized clinical trial. J Periodontol. 2012;83(9):1086-94.
31. Vinholis AH, Figueiredo LC, Marcantonio Junior E, Marcantonio RA, Salvador SL, Goissis G. Subgingival utilization of a 1% chlorhexidine collagen gel for the treatment of periodontal pockets. A clinical and microbiological study. Braz Dent J. 2001;12(3):209-13.
32. Cetin EO, Buduneli N, Atlihan E, Kirilmaz L. In vitro studies of a degradable device for controlledrelease of meloxicam. J Clin Periodontol. 2005;32(7):773-7.
33. Karthikeyan K, Durgadevi R, Saravanan K, Shivsankar K, Usha S, Saravanan M. Formulation of bioadhesive carbomer gel incorporating drug-loaded gelatin microspheres for periodontal therapy. Trop J Pharm Res. 2012;11(3):335-43.
34. Heijl L, Dahlen G, Sundin Y, Wenander A, Goodson JM. A 4-quadrant comparative study of periodontal treatment using tetracycline-containing drug delivery fibers and scaling. J Clin Periodontol. 1991;18(2):111-6.
35. Qin Y, Yuan M, Li L, Li W, Xue J. Formulation and evaluation of in situ forming PLA implant containing tinidazole for the treatment of periodontitis. J Biomed Mater Res Part B. 2012;100(8):2197-202.
36. Reise M, Wyrwa R, Muller U, Zylinski M, Volpel A, Schnabelrauch M. Release of metronidazole from electrospun poly(L-lactide-co-D/L-lactide) fibers for local periodontitis treatment. Dent Mater. 2012;28(2):179-88.
37. Di Turi G, Riggio C, Vittorio O, Marconcini S, Briguglio F, Funel N. Sub-micrometric liposomes as drug delivery systems in the treatment of periodontitis. Int J Iimmunopathol pharmacol. 2012;25(3):657-70.
38. Corry D, Moran J. Assessment of acrylic bone cement as a local delivery vehicle for the application of non-steroidal anti-inflammatory drugs. Biomaterials. 1998;19(14):1295-301.
39. Gardiner J, Freeman S, Leach M, Green A, Alcock J, D'Emanuele A. PAMAM dendrimers for the delivery of the antibacterial Triclosan. J Enzyme Inhib Med Chem. 2008;23(5):623-8.
40. Sharma A, Pradeep AR. Clinical efficacy of 1% alendronate gel in adjunct to mechanotherapy in the treatment of aggressive periodontitis: a randomized controlled clinical trial. J Periodontol. 2012;83(1):19-26.
41. Moran J, Addy M, Wade W, Newcombe R. The use of antimicrobial acrylic strips in the nonsurgical management of chronic periodontitis. Clin Mater. 1990;6(2):123-35.
42. Abu Fanas SH, Drucker DB, Hull PS. Evaluation of acrylic strips containing amoxycillin with clavulanic acid for local drug delivery. J Dent. 1991;19(2):92-6.
43. Ozcan G, Taner IL, Doganay T, Iscanoglu M, Taplamacioglu B, Gultekin SE. Use of membranes containing 20% chlorhexidine and 40% doxycycline for treatment of chronic periodontal pockets. J Nihon Univ Sch Dent. 1994;36(3):191-8.
44. Fan MW, Wei GX, Liu NH, Ling JQ. [A study on resorbable local metronidazol delivery devices]. Shanghai Kou Qiang Yi Xue. 1992;1(1):22-4.
45. Noguchi T, Izumizawa K, Fukuda M, Kitamura S, Suzuki Y, Ikura H. New method for local drug delivery using resorbable base material in periodontal therapy. Bull Tokyo Med Dent Univ. 1984;31(3):145-53.
46. Roskos KV, Fritzinger BK, Rao SS, Armitage GC, Heller J. Development of a drug delivery system for the treatment of periodontal disease based on bioerodible poly(ortho esters). Biomaterials. 1995;16(4):313-7.
47. Ahuja A, Ali J, Rahman S. Biodegradable periodontal intrapocket device containing metronidazole and amoxycillin: formulation and characterisation. Die Pharm. 2006;61(1):25-9.
48. Liu DZ, Chen WP, Lee CP, Wu SL, Wang YC, Chung TW. Effects of alginate coated on PLGA microspheres for delivery tetracycline hydrochloride to periodontal pockets. J Microencapsul. 2004;21(6):643-52.
49. Kyun KD, Yun KS, Young JS, Pyoung CC, Heui SS. [Development of minocycline containing polycaprolactone film as a local drug delivery]. Taehan Ch'ikkwa Uisa Hyophoe Chi. 1990;28(3):279-90.
50. Arrona G, DeRosa A, Rosso F. A biocompatibility study of the effects of slow-release antibiotic materials in the treatment of periodontal disease-I. the biocompatibility of cellulose acetate charged with 25% tetracycline hydrochloride. a clinical and scanning microscopic study of a case. Minerva Stomatol. 1998;47:553-7.
51. Srinivas M, Medaiah S, Girish S, Anil M, Pai J, Walvekar A. The effect of ketoprofen in chronic periodontitis: a clinical double-blind study. J Indian Soc Periodontol. 2011;15(3):255-9.
52. Sato S, Fonseca MJ, Ciampo JO, Jabor JR, Pedrazzi V. Metronidazole-containing gel for the treatment of periodontitis: an in vivo evaluation. Braz Oral Res. 2008;22(2):145-50.
53. Lecio G, Shaddox LM, Diniz Carvalho M, Duarte PM, Santos Tunes R, Nogueira-Filho GR. Subgingival triclosan-polydimethylsiloxane gel as an adjunct to scaling and root planing. Am J Dent. 2008;21(3):171-4.
54. Deasy PB, Collins AE, MacCarthy DJ, Russell RJ. Use of strips containing tetracycline hydrochlo ride or metronidazole for the treatment of advanced periodontal disease. J Pharm Pharmacol. 1989;41(10):694-9.
55. Victor SP, Kumar TS. BCP ceramic microspheres as drug delivery carriers: synthesis, characterisation and doxycycline release. J Maters Sci Mater Med. 2008;19(1):283-90.
56. Perugini P, Genta I, Conti B, Modena T, Pavanetto F. Periodontal delivery of ipriflavone: new chitosan/ PLGA film delivery system for a lipophilic drug. Int J Pharm. 2003;252(1-2):1-9.
57. Wang LC, Wu H, Chen XG, De Li L, Ji QX, Liu CS. Biological evaluation of a novel chitosan-PVA-based local delivery system for treatment of periodontitis. J Biomed Mater Res Part A. 2009;91A(4):1065-76.
58. Kelly HM, Deasy PB, Ziaka E, Claffey N. Formulation and preliminary in vivo dog studies of a novel drug delivery system for the treatment of periodontitis. Int J Pharm. 2004;274(1-2):167-83.
59. Saboktakin MR, Tabatabaie RM, Maharramov A, Ramazanov MA. Development and in vitro evaluation of thiolated chitosan-poly(methacrylic acid) nanoparticles as a local mucoadhesive delivery system. Int J Biol Macromol. 2011;48(3):403-7.
60. Park YJ, Lee JY, Yeom HR, Kim KH, Lee SC, Shim IK. Injectable polysaccharide microcapsules for prolonged release of minocycline for the treatment of periodontitis. Biotechnol Lett. 2005;27(22):1761-6.
61. Obaidat AA, Altamimi RM, Hammad MM. Formulation and release of doxycycline HCL from an ion activated in situ gelling delivery system for the treatment of periodontal disease. J Appl Polym Sci. 2010;115(2):811-6.
62. Mundargi RC, Srirangarajan S, Agnihotri SA, Patil SA, Ravindra S, Setty SB. Development and evaluation of novel biodegradable microspheres based on poly(d, l-lactide-co-glycolide) and poly(epsilon-caprolactone) for controlled delivery of doxycycline in the treatment of human periodontal pocket: in vitro and in vivo studies. J Control Release. 2007;119(1):59-68.
63. Shifrovitch Y, Binderman I, Bahar H, Berdicevsky I, Zilberman M. Metronidazole-loaded bioabsorbable films as local antibacterial treatment of infected periodontal pockets. J Periodontol. 2009;80(2):330-7.
64. Yue IC, Poff J, Cortes ME, Sinisterra RD, Faris CB, Hildgen P. A novel polymeric chlorhexidine delivery device for the treatment of periodontal disease. Biomaterials. 2004;25(17):3743-50.
65. Varshosaz J, Tavakoli N, Saidian S. Development and physical characterization of a periodontal bioadhesive gel of metronidazole. Drug Del. 2002;9(2):127-33.
66. Gad H, El-Nabarawi M, Abd El-Hady S. Formulation and evaluation of PLA and PLGA in situ implants containing secnidazole and/or doxycycline for treatment of periodontitis. AAPS PharmSci-Tech. 2008;9(3):878-84.
67. de Sousa FO, Blanco-Méndez J, Pérez-Estévez A, Seoane-Prado R, Luzardo-Álvarez A. Effect of zein on biodegradable inserts for the delivery of tetracycline within periodontal pockets. J Biomater Appl. 2012;27(2):187-200.
68. Pinon-Segundo E, Ganem-Quintanar A, Alonso-Perez V, Quintanar-Guerrero D. Preparation and characterization of triclosan nanoparticles for periodontal treatment. Int J Pharm. 2005;294(1-2):217-32.
69. Sendil D, Gursel I, Wise DL, Hasirci V. Antibiotic release from biodegradable PHBV microparticles. J Control Release.1999;59(2):207-17
70. Johnson ML, Uhrich KE. Concurrent release of admixed antimicrobials and salicylic acid from salicylate-based poly (anhydride-esters). J Biomed Mater Res Part A. 2009;91(3):671-8.
71. Zamani M, Morshed M, Varshosaz J, Jannesari M. Controlled release of metronidazole benzoate from poly epsilon-caprolactone electrospun nanofibers for periodontal diseases. Eur J Pharm Biopharm. 2010;75(2):179-85.
72. Schwach-Abdellaoui K, Monti A, Barr J, Heller J, Gurny R. Optimization of a novel bioerodible device based on auto-catalyzed poly(ortho esters) for controlled delivery of tetracycline to periodontal pocket. Biomaterials. 2001;22(12):1659-66.
73. Golomb G, Friedman M, Soskolne A, Stabholz A, Sela MN. Sustained release device containing metronidazole for periodontal use. J Dent Res. 1984;63(9):1149-53.
74. Venkatesh MP, Kumar TM, Avinash BS, Kumar GS. Development, in vitro and in vivo evaluation of novel injectable smart gels of azithromycin for chronic periodontitis. Curr Drug Deliv. 2013;10(2):188-97.
75. Jones DS, Woolfson AD, Djokic J, Coulter WA. Development and mechanical characterization of bioadhesive semi-solid, polymeric systems containing tetracycline for the treatment of periodontal diseases. Pharm Res. 1996;13(11):1734-8.
76. Taner IL, Ozcan G, Doganay T, Iscanolu M, Taplamacioglu B, Gultekin SE. Comparison of the antibacterial effects on subgingival microflora of two different resorbable base materials containing doxycycline. J Nihon Univ Sch Dent. 1994;36(3):183-90.
77. Garg T, Singh S, Arora S, RSR M. Dendrimer-a novel scaffold for cell and drug delivery. Int J Pharm Sci Rev Res. 2011;7(2):211-20.
78. Pragati S, Ashok S, Kuldeep S. Recent advances in periodontal drug delivery systems. Int J Drug Deliv. 2011;1(1):15-23.
79. Kenawy E-R, Bowlin GL, Mansfield K, Layman J, Simpson DG, Sanders EH. Release of tetracycline hydrochloride from electrospun poly (ethylene-co-vinylacetate), poly (lactic acid), and a blend. J Control Release. 2002;81(1):57-64.
80. Chaturvedi T, Srivastava R, Srivastava A, Gupta V, Verma P. Evaluation of metronidazole nanofibers in patients with chronic periodontitis: A clinical study. International J Pharmaceutical Investigation. 2012;2(4):213-7.
81. Sachdeva S, Agarwal V. Evaluation of commercially available biodegradable tetracycline fiber therapy in chronic periodontitis. J Indian Soc Periodontol. 2011;1:130-4.
82. Vanden Bogaerde L. Treatment of infrabony periodontal defects with esterified hyaluronic acid: clinical report of 19 consecutive lesions. Int J Periodont Restorat Dent. 2009;29(3):315-23.
83. Sakellari D, Vouros ID, Aristodemou E, Konstantinidis AB, Socransky S, Goodson M. Tetracycline fibers as an adjunct in the treatment of nifedipine-induced gingival enlargement. J periodontol. 2005;76(6):1034-9.
84. Yalcin F, Demirel K, Onan U. Evaluation of adjunctive tetracycline fiber therapy with scaling and root planing: short-term clinical results. Periodont Clin Invest. 1999;21(2):23-7.
85. Latner L. Patient selection and clinical applications of periodontal tetracycline fibers. Gen Dent. 1998;46(1):58-61.
86. Vandekerckhove BN, Quirynen M, van Steenberghe D. The use of tetracycline-containing controlled-release fibers in the treatment of refractory periodontitis. J Periodont. 1997;68(4):353-61.
87. Tonetti M, Cugini MA, Goodson JM. Zero-order delivery with periodontal placement of tetracycline-loaded ethylene vinyl acetate fibers. J Periodont Res. 1990;25(4):243-9.
88. Goodson JM, Holborow D, Dunn RL, Hogan P, Dunham S. Monolithic tetracycline-containing fibers for controlled delivery to periodontal pockets. J Periodontol. 1983;54(10):575-9.
89. Jones DS, Medlicott NJ. Casting solvent controlled release of chlorhexidine from ethylcellulose films prepared by solvent evaporation. Int J Pharm. 1995;114(2):257-61.
90. Valappil SP, Coombes M, Wright L, Owens GJ, Lynch RJ, Hope CK. Role of gallium and silver from phosphate-based glasses on in vitro dual species oral biofilm models of Porphyromonas gingivalis and Streptococcus gordonii. Acta Biomater. 2012;8(5):1957-65.
91. Kandelaki K, Alavidze N, Pkhakadze I, Dgebuadze M, Melikadze E. [Reaction of gingival mucosa on the biodegradated film under chronic periodontitis treatment: morpho-functional correlation]. Georgian Med News. 2011(198):13-8.
92. Ahuja A, Rahman S, Ali J, Chaudhry R. Effect of dental films containing amoxycillin and metronidazole on periodontal pathogens: microbiological response. Die Pharm. 2003;58(10):716-20.
93. Ikinci G, Senel S, Akincibay H, Kas S, Ercis S, Wilson CG. Effect of chitosan on a periodontal pathogen Porphyromonas gingivalis. Int J Pharm. 2002;235(1-2):121-7.
94. Dedeian VR, Solov'eva NI, Ezikian TI, Medvedeva IA. [The treatment of periodontal diseases using Diplen-Denta films with chlorhexidine (a clinico-laboratory study)]. Stomatologiia. 1997;76(4):18-22.
95. Kozlovsky A, Sintov A, Moldovan M, Tal H. Inhibition of plaque formation by local application of a degradable controlled release system containing cetylpyridinium chloride. J Clin Periodontol. 1994;21(1):32-7.
96. Minabe M, Takeuchi K, Nishimura T, Hori T, Umemoto T. Therapeutic effects of combined treatment using tetracycline-immobilized collagen film and root planing in periodontal furcation pockets. J Clin Periodontol. 1991;18(5):287-90.
97. Steinberg D, Friedman M, Soskolne A, Sela MN. A new degradable controlled release device for treatment of periodontal disease: in vitro release study. J Periodontol. 1990;61(7):393-8.
98. Bruschi ML, Jones DS, Panzeri H, Gremião MP, de Freitas O, Lara EH. Semisolid systems containing propolis for the treatment of periodontal disease: in vitro release kinetics, syringeability, rheological, textural, and mucoadhesive properties. J Pharm Sci. 2007;96(8):2074-89.
99. Zhao Y, Kang J, Tan T. Salt-, pH-and temperature-responsive semi-interpenetrating polymer network hydrogel based on poly (aspartic acid) and poly (acrylic acid). Polymer. 2006;47(22):7702-10.
100. Garg T, Singh S, Goyal AK. Stimuli-sensitive hydrogels: an excellent carrier for drug and cell delivery. Crit Rev Ther Drug Carrier Syst. 2013;30(5):369-409.
101. Mehta R. Topical and transdermal drug delivery: what a pharmacist needs to know. Midwestern University College of Pharmacy-Glendale, ACPE ID. 2000(146-000):01-008.
102. Singh A, Sharma PK, Garg VK, Garg G. Hydrogels: a review. Int J Pharm Sci Rev Res. 2010;4(2):97-103.
103. Agarwal E, Pradeep AR, Bajaj P, Naik SB. Efficacy of local drug delivery of 0.5% clarithromycin gel as an adjunct to non-surgical periodontal therapy in the treatment of current smokers with chronic periodontitis: a randomized controlled clinical trial. J Periodontol. 2012;83(9):1155-63.
104. Pradeep AR, Sharma A, Rao NS, Bajaj P, Naik SB, Kumari M. Local drug delivery of alendronate gel for the treatment of patients with chronic periodontitis with diabetes mellitus: a double-masked controlled clinical trial. J Periodontol. 2012;83(10):1322-8.
105. Ahmed M, Sureka J, Koshy CG, Chacko BR, Chacko G. Langerhans cell histiocytosis of the clivus: an unusual cause of a destructive central skull base mass in a child. Neurol India. 2012;60(3):346-8.
106. Funosas E, Feser G, Escovich L, Maestri L. Alteration of hemostasis in patients treated with subgingival NSAIDs during periodontal therapy. Acta Odontol Latinoam. 2012;25(1):103-8.
107. Chava VK, Vedula BD. Thermo Reversible Green Tea Catechin Gel for Local Application in Chronic Periodontitis-A 4 Week Clinical Trial. J Periodontol. 2013;84(9):1290-6.
108. Pradeep AR, Agarwal E, Bajaj P, Naik SB, Kumari M, Guruprasad CN. Clinical and microbiological effects of commercially available dentifrice containing amine fluoride: A randomized controlled clinical trial. Contemporary clinical dentistry. 2012;3(3):265-70.
109. Agarwal E, Bajaj P, Naik SB, Pradeep AR. Locally delivered 0.5% azithromycin, as an adjunct to non surgical treatment in chronic periodontitis with type 2 diabetes: a randomized controlled clinical trial. J Periodontol. 2012;1:1-10.
110. Calderini A, Pantaleo G, Rossi A, Gazzolo D, Polizzi E. Adjunctive effect of chlorhexidine antiseptics in mechanical periodontal treatment: first results of a preliminary case series. Int J Dent Hyg. 2012;11(3):180-5.
111. Gontiya G, Galgali SR. Effect of hyaluronan on periodontitis: a clinical and histological study. J Indian Soc Periodontol. 2012;16(2):184-92.
112. Pilloni A, Annibali S, Dominici F, Di Paolo C, Papa M, Cassini MA. Evaluation of the efficacy of an hyaluronic acid-based biogel on periodontal clinical parameters. a randomized-controlled clinical pilot study. Ann Stomatol. 2011;2(3-4):3-9.
113. Tiwari G, Tiwari R, Rai AK. Studies on development of controlled delivery of combination drug(s) to periodontal pocket. Indian J Dental Res. 2010;21(1):72-83.
114. Bansal K, Rawat MK, Jain A, Rajput A, Chaturvedi TP, Singh S. Development of satranidazole mucoadhesive gel for the treatment of periodontitis. AAPS PharmSciTech. 2009;10(3):716-23.
115. Boynuegri D, Ozcan G, Senel S, Uc D, Uraz A, Ogus E. Clinical and radiographic evaluations of chitosan gel in periodontal intraosseous defects: a pilot study. J Biomed Mater Res Part B. 2009;90(1):461-6.
116. Yang JH, Yun MY, Kim DK, Kim MJ, Kim YI, Kim TY. Preparation and evaluation of ketorolac tromethamine gel containing genipin for periodontal diseases. Arch Pharm Res. 2007;30(7):871-5.
117. Maze GI, Reinhardt RA, Payne JB, Maze C, Baker RA, Bouwsma OJ. Gingival fluid tetracycline release from bioerodible gels. J Clin Periodontol. 1996;23(12):1133-6.
118. Struillou X, Boutigny H, Badran Z, Fellah BH, Gauthier O, Sourice S. Treatment of periodontal defects in dogs using an injectable composite hydrogel/biphasic calcium phosphate. J Mater Sci Mater Med. 2011;22(7):1707-17.
119. Ma ZW, Zhang YJ, Wang R, Wang QT, Dong GY, Wu ZF. [An animal experiment for the regeneration of periodontal defect by application of the dual-release chitosan thermosensitive hydrogel system]. Zhonghua Kou Qiang Yi Xue Za Zhi. 2008;43(5):273-7.
120. Ahmad FJ, Iqbal Z, Jain N, Jain GK, Talegaonkar S, Ahuja A. Dental therapeutic systems. Recent Patents Drug Deliv Formul. 2008;2(1):58-67.
121. Schwach-Abdellaoui K, Vivien-Castioni N, Gurny R. Local delivery of antimicrobial agents for the treatment of periodontal diseases. Eur J Pharm Biopharm. 2000;50(1):83-99.
122. Leung WK, Jin L, Yau JY, Sun Q, Corbet EF. Microflora cultivable from minocycline strips placed in persisting periodontal pockets. Arch Oral Biol. 2005;50(1):39-48.
123. Maze GI, Reinhardt RA, Agarwal RK, Dyer JK, Robinson DH, DuBois LM. Response to intracrevicular controlled delivery of 25% tetracycline from poly(lactide/glycolide) film strips in SPT patients. J Clin Periodontol. 1995;22(11):860-7.
124. Addy M, Langeroudi M. Comparison of the immediate effects on the sub-gingival microflora of acrylic strips containing 40% chlorhexidine, metronidazole or tetracycline. J Clin Periodontol. 1984;11(6):379-86.
125. Patel N, Panda S. Liposome Drug delivery system: a critic review. J Pharm Sci Biosci Res. 2012;2(4):162-94.
126. Patel SS. Liposome: A versatile platform for targeted delivery of drugs. Pharmainfo Net. 2006;4(5):1-5.
127. Jin HL, Wu W, Shu R. [Doxycycline nano-liposome slow-release gel improves rat periodontitis]. Shanghai Kou Qiang Yi Xue. 2010;19(5):508-11.
128. Petelin M, Pavlica Z, Ivanusa T, Sentjurc M, Skaleric U. Local delivery of liposome-encapsulated superoxide dismutase and catalase suppress periodontal inflammation in beagles. J Clin Periodontol. 2000;27(12):918-25.
129. Jayaprakash S, Halith SM, Mohamed Firthouse P, Kulaturanpillai K, Nagarajan M. Preparation and evaluation of biodegradable microspheres of methotrexate. Asian J Pharm. 2009;3(1):26-9.
130. Sam MT, Gayathri DS, Prasanth V, Vinod B. NSAIDs as microspheres. Internet J Pharmacol. 2008;6(1):1-8.
131. de Sousa FO, Blanco-Mendez J, Perez-Estevez A, Seoane-Prado R, Luzardo-Alvarez A. Effect of zein on biodegradable inserts for the delivery of tetracycline within periodontal pockets. J Biomater Appl. 2012;27(2):187-200.
132. Govender S, Lutchman D, Pillay V, Chetty DJ, Govender T. Enhancing drug incorporation into tetracycline-loaded chitosan microspheres for periodontal therapy. J Microencapsul. 2006;23(7):750-61.
133. Chen FM, Zhao YM, Wu H, Deng ZH, Wang QT, Zhou W. Enhancement of periodontal tissue regeneration by locally controlled delivery of insulin-like growth factor-I from dextran-co-gelatin microspheres. J Control Release. 2006;114(2):209-22.
134. Chen F, Wu Z, Wang Q, Wu H, Zhang Y, Nie X. Preparation and biological characteristics of recombinant human bone morphogenetic protein-2-loaded dextran-co-gelatin hydrogel microspheres, in vitro and in vivo studies. Pharmacology. 2005;75(3):133-44.
135. Parnami N, Garg T, Rath G, Goyal AK. Development and characterization of nanocarriers for topical treatment of psoriasis by using combination therapy. Artif Cells Nanomed Biotechnol. In press 2013.
136. Mohanraj V, Chen Y. Nanoparticles-a review. Trop J Pharm Res. 2007;5(1):561-73.
137. Grenha A, Seijo B, Remuñán-López C. Microencapsulated chitosan nanoparticles for lung protein delivery. European J Pharm Sci. 2005;25(4):427-37.
138. Napimoga MH, da Silva CA, Carregaro V, Farnesi-de-Assuncao TS, Duarte PM, de Melo NF. Exogenous administration of 15d-PGJ2-loaded nanocapsules inhibits bone resorption in a mouse periodontitis model. J Immunol. 2012;189(2):1043-52.
139. Klepac-Ceraj V, Patel N, Song X, Holewa C, Patel C, Kent R. Photodynamic effects of methylene blue-loaded polymeric nanoparticles on dental plaque bacteria. Lasers Surg Med. 2011;43(7):600-6.
140. Dung TH, Lee SR, Han SD, Kim SJ, Ju YM, Kim MS. Chitosan-TPP nanoparticle as a release system of antisense oligonucleotide in the oral environment. J Nanosci Nanotechnol. 2007;7(11):3695-9.
141. Arancibia R, Maturana C, Silva D, Tobar N, Tapia C, Salazar JC. Effects of chitosan particles in periodontal pathogens and gingival fibroblasts. J Dent Res. 2013;92(8):740-5.
142. Lu Z, Rong K, Li J, Yang H, Chen R. Size-dependent antibacterial activities of silver nanoparticles against oral anaerobic pathogenic bacteria. J Mater Sci Mater Med. 2013;24(6):1465-71.
143. Javed S, Kohli K. Local delivery of minocycline hydrochloride: a therapeutic paradigm in periodontal diseases. Curr Drug Deliv. 2010;7(5):398-406.
144. Zhang SM, Tian F, Jiang XQ, Li J, Xu C, Guo XK. Evidence for calcifying nanoparticles in gingival crevicular fluid and dental calculus in periodontitis. J Periodontol. 2009;80(9):1462-70.